Register | Login |

bookCompanies overview

Procter & Gamble

    The Procter & Gamble Company Type Public (NYSE: PG) Dow Jones Industrial Average Component Industry Consumer goods Founded 1837 Headquarters Cincinnati, Ohio, U.S. Area served Worldwide Key people Bob McDonald (President) & (CEO) Products See List of Procter & Gamble brands Revenue ▲ US$79.03 billion (2009)[1] Operating income ▲ $16.13 billion (2009)[1] Net income ▲ $13.44 billion (2009)[1] Total assets ▲ $134.83 billion (2009)[1] [...]

Read More »
At 02 Sep 2010 - In Companies overview

Genentech

Genentech Inc., a portmanteau of Genetic Engineering Technology, Inc., is a biotechnologycorporation, which was founded in 1976 by venture capitalist Robert A. Swanson and biochemist Dr. Herbert Boyer.[1][2] It is considered to have founded the biotechnology industry.[1][2] One of its founders, Boyer, is considered to be a pioneer in the field of recombinant DNA technology. In1973, Boyer and his colleague Stanley Norman Cohen demonstrated that restriction enzymescould be used as “scissors” [...]

Read More »
At 02 Sep 2010 - In Companies overview

Takeda Pharmaceutical Company

Takeda Pharmaceutical Company Limited (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha?) (TYO: 4502) is the largest pharmaceutical company in Japan and Asia and a top 15 pharmaceutical company. The company has over 19,000 employees worldwide and achieved $15.7 billion USD in revenue during the 2008 fiscal year.[1] The company is focused onmetabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Millennium: The Takeda Oncology Company.[2] Contents [hide] 1 History [...]

Read More »
At 02 Sep 2010 - In Companies overview

Baxter International

Baxter International Inc. (NYSE: BAX), is an American health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treathemophilia, kidney disease, immune disorders and other chronic and acute medical conditions. The company has sales of $12.3 billion, across three manufacturing divisions (BioScience, producing blood plasma proteins; Medication Delivery producing intravenous therapy products and liquids; and Renal producing equipment for dialysis and the treatment [...]

Read More »
At 02 Sep 2010 - In Companies overview

Schering-Plough

The former Schering-Plough Corporation was a global pharmaceutical company based in theUnited States. It was founded in 1851 by Ernst Christian Friedrich Schering as Schering AG inGermany. In 1971, the Schering Corporation merged with Plough (founded by Memphis area entrepreneur Abe Plough in 1908 [1]) to form Schering-Plough. Schering-Plough manufactures several pharmaceutical drugs, the most well-known of which are the allergy drugs Claritin and Clarinex, and through [...]

Read More »
At 02 Sep 2010 - In Companies overview

Boehringer Ingelheim

Boehringer Ingelheim GmbH is a pharmaceutical company which concentrates on the development of human pharmaceuticals, biopharmaceuticals, chemicals, and animal health products. The Human Pharmaceuticals sector is the company’s largest division, accounting for about 96% of sales. This includes prescription medicines and consumer healthcare products. Boehringer Ingelheim is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).[1] Contents [...]

Read More »
At 02 Sep 2010 - In Companies overview

Amgen

Amgen Inc. (NASDAQ: AMGN, SEHK: 4332) is an international biotechnology companyheadquartered in Thousand Oaks, California. Located in the Conejo Valley, Amgen is the world’s largest independent biotech firm. The company employs approximately 17,000 staff members. Its products include Epogen, Aranesp, Enbrel, Kineret, Neulasta, Neupogen, Sensipar / Mimpara, Nplate, and Prolia. Epogen and Neupogen (the company’s first products on the market) were the two most successful biopharmaceutical products at the time of their respective releases. [...]

Read More »
At 02 Sep 2010 - In Companies overview

Eli Lilly and Company

For other uses, see Eli Lilly (disambiguation). Eli Lilly and Company Type Public (NYSE: LLY) Industry Pharmaceuticals, Healthcare Founded 1876 Headquarters Indianapolis, Indiana, USA Key people Sidney Taurel, Chairman John C. Lechleiter, President & CEO Derica Rice, CFO Eli Lilly, Founder Products Prozac, Humalog, Cialis, Strattera, Darvocet Revenue ▲ US$21.8 Billion (FY 2009)[1] Operating income ▲ US$5.66 Billion (FY 2009)[1] Net income ▲ US$4.33 [...]

Read More »
At 02 Sep 2010 - In Companies overview

Bristol-Myers Squibb

“Squibb” redirects here. It is not to be confused with Squib. Bristol-Myers Squibb Company Type Public NYSE: BMY Industry Pharmaceuticals Founded 1887 Headquarters New York, New York Key people Lamberto Andreotti, CEO Revenue ▲ US$18.8 Billion (FY 2009)[1] Operating income ▲ US$5.34 Billion (FY 2009)[1] Net income ▲ US$10.6 Billion (FY 2009)[1] Total assets ▲ US$31.0 Billion (FY 2009)[2] Total equity ▲ US$14.8 Billion (FY 2009)[2] Employees 35,000 [...]

Read More »
At 02 Sep 2010 - In Companies overview

Wyeth

This article is about the corporation. For other uses of the word, see Wyeth (disambiguation). Wyeth Type Subsidiary Industry Pharmaceuticals, Healthcare Founded (1860) Philadelphia,Pennsylvania, U.S. Headquarters Madison, New Jersey,  United States Key people Bernard J. Poussot, CEO, President and Vice Chairman of Wyeth Robert Essner, Chairman Joseph Mahady, President, Global Business, Wyeth Pharmaceuticals John Wyeth, Founder Products Premarin, Effexor, Enbrel, [...]

Read More »
At 02 Sep 2010 - In Companies overview

Abbott Laboratories

Abbott Laboratories (NYSE: ABT) is a pharmaceuticals health care company. It has 72,000 employees and operates in over 130 countries.[3] The company headquarters are in Abbott Park,Illinois, located near North Chicago, Illinois. Abbott Laboratories was founded by Chicago physician Wallace Calvin Abbott in 1888. In 2008, Abbott had over $29 billion in revenue. In 1985, the company developed the first HIV blood screening test. The company’s [...]

Read More »
At 02 Sep 2010 - In Companies overview

Merck & Co.

This article needs additional citations for verification. Please help improve this article by adding reliable references. Unsourced material may be challenged and removed.(March 2010) Merck & Co., Inc. (Merck Sharp & Dohme (MSD) outside the United States and Canada) Type Public (NYSE: MRK) Dow Jones Industrial Average Component Industry Pharmaceuticals Founded 1891 as a subsidiary of Merck KGaA 1917 as an independent company Headquarters Whitehouse Station, New Jersey, United States [...]

Read More »
At 02 Sep 2010 - In Companies overview

AstraZeneca

This article needs additional citations for verification. Please help improve this article by adding reliable references. Unsourced material may be challenged and removed.(October 2009) AstraZeneca plc Type Public limited company (LSE: AZN,NASDAQ: AZN,OMX: AZN) Industry Pharmaceutical Founded 6 April 1999 by merger Headquarters London, United Kingdom Key people Louis Schweitzer, Chairman David R. Brennan, Chief Executive Officer Products Pharmaceutical products for humans Revenue $32,804 million (2009)[1] Operating income $11,543 million (2009)[1] Net [...]

Read More »
At 02 Sep 2010 - In Companies overview

Hoffmann–La Roche

F. Hoffmann–La Roche Ltd. is a Swiss global health-care company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange (SIX: ROG). The company headquarters are located in Basel and the company has many sites around the world – including: Nutley, NJ, Palo Alto, California, Pleasanton, Branchburg, Fishers, Indiana,Florence, South Carolina, Boulder, Colorado and Ponce, Puerto Rico in the US, Welwyn Garden City and Burgess Hill in [...]

Read More »
At 02 Sep 2010 - In Companies overview

Sanofi-Aventis

Sanofi-Aventis (Euronext: SAN, NYSE: SNY), headquartered in Paris, France, is a multinational pharmaceutical company, the world’s fourth-largest by prescription sales.[2][3]Sanofi-Aventis engages in the research and development, manufacturing and marketing of pharmaceutical products for sale principally in the prescription market, but the firm also developsover-the-counter medication. Sanofi-Aventis covers 7 major therapeutic areas: cardiovascular,central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines (it is the world’s largest producer of the [...]

Read More »
At 02 Sep 2010 - In Companies overview

Johnson & Johnson

Not to be confused with S.C. Johnson. Johnson & Johnson   Type  Public (NYSE: JNJ) Dow Jones Industrial Average Component Industry  Major drugs Health care Soaps Shampoos Founded 1886 Founder(s) Robert Wood Johnson I James Wood Johnson Edward Mead Johnson Headquarters New Brunswick, NJ, U.S. Area served Worldwide Key people William C. Weldon (Chairman) & (CEO) [...]

Read More »
At 01 Sep 2010 - In Companies overview

GlaxoSmithKline

GlaxoSmithKline plc (LSE: GSK NYSE: GSK), often abbreviated to GSK, is a global pharmaceutical, biologics, vaccines and consumer healthcare company headquartered in London, United Kingdom. It is the world’s third largest pharmaceutical company measured by revenues (after Johnson & Johnson and Pfizer).[3] It has a portfolio of products for major disease areas including asthma, cancer, virus [...]

Read More »
At 01 Sep 2010 - In Companies overview

Bayer

This article is about the chemical and pharmaceutical company. For other uses, see Bayer (disambiguation). Not to be confused with Beyer. Bayer AG Type  Public (FWB: BAYN, TYO: 4863) Industry  Pharmaceuticals, chemicals Founded 1863 Founder(s)  Friedrich Bayer, Johann Friedrich Weskott Headquarters Leverkusen, Germany Key people Werner Wenning (CEO), Manfred Schneider (Chairman of the supervisory board) [...]

Read More »
At 01 Sep 2010 - In Companies overview

Novartis

Novartis International AG is a multinational pharmaceutical company based in Basel, Switzerland, ranking number three in sales among the world-wide industry, which accounted 36.173 billon in 2008.[3] It currently is the sixth largest pharmaceutical company in terms of revenue ($41.5 billion in 2009) with a profit margin of about 20%, which is the same as [...]

Read More »
At 24 Aug 2010 - In Companies overview